The drug, called Staphefekt, is based on a naturally-occurring enzyme that side-steps the defence mechanisms that superbugs have evolved to fight off traditional antibiotics. It is already available in Holland and Germany as a cream to treat skin infections such as acne, but researchers hope to develop a tablet form of the drug within five years to treat serious infections.